Advertisement Nerites receives NIH grant for bacterial infection study - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nerites receives NIH grant for bacterial infection study

Nerites has received a $100,000 small business innovation research grant from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, for testing its unique new technology for preventing bacterial infections.

The study will determine whether Nerites novel polymer coatings can prevent biofilm growth, the source of most infections on urinary stents and catheters. Biofilms grow on the surface of the device and provide an anchor for bacteria, which then recruit other bacteria and cause infection.

Thomas Mozer, CEO and president of Nerites, said: “This money will help us test our coating technology, which we believe will block biofilm formation reliably and inexpensively, without antibiotics or biocides.”